MDxHealth
MDXH
22 hedge funds and large institutions have $47.4M invested in MDxHealth in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 0 closing their positions.
144% more funds holding
Funds holding: 9 → 22 (+13)
126% more capital invested
Capital invested by funds: $21M → $47.4M (+$26.4M)
15.5% more ownership
Funds ownership: 32.76% → 48.26% (+15%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$12.2M |
| 2 |
AIC
AWM Investment Company
New York
|
+$11.5M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.73M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$2.72M |
Top Sellers
MDXH Hedge Fund Activity: Q3 2024 in Review
22 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q3 2024, worth a combined $47.4M — up 126% from $21M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new MDXH positions and 0 closed out — a net gain of 13 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Bleichroeder LP, adding an estimated $12.2M.
- 22 institutional investors held MDxHealth (MDXH) as of Q3 2024, up from 9 in Q2 2024.
- Funds reported $47.4M of MDxHealth stock for Q3 2024, up 126% quarter-over-quarter.
- 13 funds opened new MDxHealth positions in Q3 2024 and 0 closed out, a net change of +13 holders.
- The largest MDxHealth buyer in Q3 2024 was Bleichroeder LP, an estimated $12.2M added.
Based on aggregated 13F filings for Q3 2024.